A herpes virus peptide binds and sequesters proteins important for MYC activation in lymphoma cells, presenting a new viral strategy for treating undruggable MYC-dependent cancers.
Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.
Discover how innovative proteomics tools help researchers peer into once inaccessible organelles, allowing for new targets for drug discovery and development.